Please sign in to follow a disease.
Invasive lobular carcinoma
Clinical trials for Invasive lobular carcinoma explained in plain language.
Never miss a new study
Get alerted when new Invasive lobular carcinoma trials appear
Sign up with your email to follow new studies for Invasive lobular carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Breast cancer trial combines targeted drug with hormone therapy to shrink tumors before surgery
Disease control OngoingThis phase 2 trial investigates whether adding the targeted drug palbociclib to standard endocrine therapy (letrozole or tamoxifen) improves tumor shrinkage before surgery in people with hormone receptor positive, HER2 negative breast cancer. The study includes both invasive lobu…
Matched conditions: INVASIVE LOBULAR CARCINOMA
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New PET scan aims to spot hidden cancer spread
Diagnosis OngoingThis early-phase study is testing whether a special PET scan using a drug called PYLARIFY can better detect cancer that has spread in people with pancreatic cancer, liver cancer, or breast cancer. About 36 adults will receive the scan, and doctors will compare the results to stan…
Matched conditions: INVASIVE LOBULAR CARCINOMA
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
Scientists probe Fat-Breast cancer link in 150 patients
Knowledge-focused OngoingThe FATLAS study is looking at how body fat (adiposity) influences breast cancer at both the whole-body and cellular levels. Researchers will enroll 150 breast cancer patients with different body types (lean, overweight, obese) and collect blood, tumor tissue, and body measuremen…
Matched conditions: INVASIVE LOBULAR CARCINOMA
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC